Beneficials Effects of Canagliflozin in a Weight-Centered Management in Patients With Type 2 Diabetes Mellitus in Real Practice

Endocrinology & Metabolic Syndrome
doi 10.4172/2161-1017.1000286
Full Text
Abstract

Available in full text

Date
Authors
Publisher

OMICS Publishing Group

Related search

Characteristics and Outcomes of Patients With Type 2 Diabetes Mellitus Treated With Canagliflozin: A Real-World Analysis

BMC Endocrine Disorders
MedicineEndocrinologyMetabolismDiabetes
2015English

Effect of Canagliflozin on Serum Uric Acid in Patients With Type 2 Diabetes Mellitus

Diabetes, Obesity and Metabolism
Internal MedicineEndocrinologyMetabolismDiabetes
2015English

Pharmacokinetics, Pharmacodynamics, and Safety of Canagliflozin in Japanese Patients With Type 2 Diabetes Mellitus

Advances in Therapy
MedicinePharmacology
2015English

The Importance of Weight Management in Type 2 Diabetes Mellitus

International Journal of Clinical Practice
Medicine
2014English

Practice of Dapagliflozin Application in Patients With Type 2 Diabetes Mellitus

INTERNATIONAL JOURNAL OF ENDOCRINOLOGY
2015English

Clinical Implications of Canagliflozin Treatment in Patients With Type 2 Diabetes

Clinical Diabetes
Internal MedicineEndocrinologyMetabolismDiabetes
2015English

The CANVAS Program: Implications of Canagliflozin on Reducing Cardiovascular Risk in Patients With Type 2 Diabetes Mellitus

Cardiovascular Diabetology
Internal MedicineCardiologyEndocrinologyCardiovascular MedicineMetabolismDiabetes
2019English

Type 2 Diabetes Mellitus Management: A Retrospective Study in Rural General Practice

Advances in Diabetes and Metabolism
2019English

Canagliflozin Improves Risk Factors of Metabolic Syndrome in Patients With Type 2 Diabetes Mellitus and Metabolic Syndrome

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
Internal MedicinePharmacology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy